192 related articles for article (PubMed ID: 10406908)
1. Therapeutic potentials of angiostatin in the treatment of cancer.
Cao Y
Haematologica; 1999 Jul; 84(7):643-50. PubMed ID: 10406908
[TBL] [Abstract][Full Text] [Related]
2. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
4. Angiostatin.
Cao Y; Xue L
Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
[TBL] [Abstract][Full Text] [Related]
5. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
6. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
Drixler TA; Borel Rinkes IH; Ritchie ED; van Vroonhoven TJ; Gebbink MF; Voest EE
Cancer Res; 2000 Mar; 60(6):1761-5. PubMed ID: 10749151
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.
Ma HI; Lin SZ; Chiang YH; Li J; Chen SL; Tsao YP; Xiao X
Gene Ther; 2002 Jan; 9(1):2-11. PubMed ID: 11850717
[TBL] [Abstract][Full Text] [Related]
8. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
10. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and cancer: recent advances.
Cáceres W; González S
P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
15. [The story of angiostatin and how controversy is useful in science].
Kurjak A
Acta Med Croatica; 2003; 57(2):145-8. PubMed ID: 12879695
[TBL] [Abstract][Full Text] [Related]
16. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
17. [Angiostatin. A biological inhibitor of tumor angiogenesis].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915
[No Abstract] [Full Text] [Related]
18. Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer.
Wilczyńska U; Kucharska A; Szary J; Szala S
Acta Biochim Pol; 2001; 48(4):1077-84. PubMed ID: 11995969
[TBL] [Abstract][Full Text] [Related]
19. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer.
Sacco MG; Caniatti M; Catò EM; Frattini A; Chiesa G; Ceruti R; Adorni F; Zecca L; Scanziani E; Vezzoni P
Cancer Res; 2000 May; 60(10):2660-5. PubMed ID: 10825138
[TBL] [Abstract][Full Text] [Related]
20. Angiostatin inhibits pathological but not physiological retinal angiogenesis.
Drixler TA; Borel Rinkes IH; Ritchie ED; Treffers FW; van Vroonhoven TJ; Gebbink MF; Voest EE
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3325-30. PubMed ID: 11726640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]